Product Description
| Cat Number | IG-010 |
|---|---|
| Category | Peptide |
| Pack Size | 1 mg |
| Description | Selective alpha-v beta-6 (αvβ6) integrin antagonist |
| Modification | C terminal amide |
| Purity | >95% by HPLC |
| Biomarker Target | Integrin receptors,Antivirals |
| Sequence Three Letter Code | H-Asn-Ala-Val-Pro-Asn-Leu-Arg-Gly-Asp-Leu-Gln-Val-Leu-Ala-Gln-Lys-Val-Ala-Arg-Thr-NH2 |
| Molecular Formula | C93H164N32O27 |
| Sl Sequence | NAVPNLRGDLQVLAQKVART-NH2 |
| Solubility | Soluble in water |
| Appearance | Freeze dried solid |
| Storage | We recommend storage desiccated, frozen and in the dark |
| References |
Hausner et al (2007) Use of a Peptide Derived from Foot-and-Mouth Disease Virus for the Noninvasive Imaging of Human Cancer: Generation and Evaluation of 4-[18F]Fluorobenzoyl A20FMDV2 for In vivo Imaging of Integrin αvβ6 Expression with Positron Emission Tomography. Cancer Res. 67(16) 7833 PMID: 17699789Slack et al (2016) Pharmacological Characterization of the αvβ6 Integrin Binding and Internalization Kinetics of the Foot-and-Mouth Disease Virus Derived Peptide A20FMDV2. Pharmacology 97(3-4) 114 PMID: 26734728 Related areasAll peptides >All antivirals >All integrin receptor modulators > |
| Note | The product is for research use only |
Share Item: